These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 19144533)

  • 1. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
    Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads.
    Kettering K; Mewis C; Dörnberger V; Vonthein R; Bosch RF; Seipel L; Kühlkamp V
    Pacing Clin Electrophysiol; 2004 Oct; 27(10):1355-61. PubMed ID: 15511244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICD Implantation in infants and small children: the extracardiac technique.
    Kriebel T; Ruschewski W; Gonzalez y Gonzalez M; Walter K; Kroll J; Kampmann C; Heinemann M; Schneider H; Paul T
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1319-25. PubMed ID: 17201837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
    Stefano B; Pietro RR; Maurizio G; Maurizio L; Renato M; Maurizio L; Pietro R; Alessandro P; Gianluca B; Monica M; Sergio C; Massimo S
    Am Heart J; 2011 Aug; 162(2):390-7. PubMed ID: 21835302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
    Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.
    Day JD; Olshansky B; Moore S; Brown S; Stolen KQ; Lerew DR;
    Europace; 2008 Mar; 10(3):347-50. PubMed ID: 18308755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvenous pectoral implantation of single lead implantable cardioverter defibrillator.
    Wang F; Hua W; Chen X
    Chin Med J (Engl); 1999 Jan; 112(1):22-4. PubMed ID: 11593633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An entirely subcutaneous implantable cardioverter-defibrillator.
    Bardy GH; Smith WM; Hood MA; Crozier IG; Melton IC; Jordaens L; Theuns D; Park RE; Wright DJ; Connelly DT; Fynn SP; Murgatroyd FD; Sperzel J; Neuzner J; Spitzer SG; Ardashev AV; Oduro A; Boersma L; Maass AH; Van Gelder IC; Wilde AA; van Dessel PF; Knops RE; Barr CS; Lupo P; Cappato R; Grace AA
    N Engl J Med; 2010 Jul; 363(1):36-44. PubMed ID: 20463331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Habitual cocaine use is associated with high defibrillation threshold during ICD implantation.
    Chen J; Naseem RH; Obel O; Joglar JA
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):722-5. PubMed ID: 17472714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.
    Gradaus R; Block M; Seidl K; Brunn J; Isgro F; Hammel D; Hauer B; Breithardt G; Bocker D
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):921-7. PubMed ID: 11513444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.